Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

33.50 

1.70 5.4%

as of May 20 '20

52 Week Range:

26.20 56.40


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Guerbet SA engages in the research, development, production, and sale of contrast media products, delivery systems, medical devices, and related solutions worldwide. Its products for the CT and Cath Lab examinations include Optiray, a low osmolar contrast medium; Xenetix, a low-osmolar iodinated agent; Telebrix, a high osmolar contrast medium; Conray and MD high osmolar contrast medium products; and high osmolar contrast medium, an ionic low osmolar contrast medium agent. The company's products for the magnetic resonance imaging (MRI) examinations comprise Dotarem, a non-specific gadolinium-based contrast medium; Artirem products; and Optimark, a contrast medium. In addition, it provides products for interventional imaging, including Lipiodol ethyl esters of iodinated fatty acids of poppy seed oil; Vectorio, a classic transarterial chemoembolization mixing and injection system; and Patent Blue V, an injectable medium. Further, the company offers delivery systems and services comprising injectors; consumables for various types of injectors; and Contrast&Care, a patient data management software. The company distributes its products directly, as well as through distributors and license-holders primarily to hospitals, clinics, radiology centers, purchasing pools, and wholesalers. Guerbet SA was founded in 1926 and is headquartered in Villepinte, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 16.87
17.26
17.39
18.54
18.80
20.28
22.26
23.80
25.83
27.65
29.24
growth rate 2.3% 0.8% 6.6% 1.4% 7.9% 9.8% 6.9% 8.5% 7.1% 5.8%
Earnings BIT 25.97
5.13
17.97
27.73
27.53
39.19
60.01
56.01
81.01
66.09
52.86
growth rate -80.3% 250.3% 54.3% -0.7% 42.4% 53.1% -6.7% 44.7% -18.4% -20.0%
Avg.PE 14.35
34.84
14.29
15.04
16.84
18.26
25.58
25.37
16.69
15.53
8.40
growth rate 142.8% -59.0% 5.3% 12.0% 8.4% 40.1% -0.8% -34.2% -7.0% -45.9%
ROA 5.27
1.44
3.31
4.48
4.45
5.59
5.81
3.00
4.66
4.60
3.57
growth rate -72.7% 129.9% 35.4% -0.7% 25.6% 3.9% -48.4% 55.3% -1.3% -22.4%
ROE 10.48
2.83
6.78
9.25
8.82
10.51
14.71
9.67
14.07
13.21
9.88
growth rate -73.0% 139.6% 36.4% -4.7% 19.2% 40.0% -34.3% 45.5% -6.1% -25.2%
ROIC 11.61
3.65
8.37
6.68
6.34
7.96
8.41
4.95
7.18
7.30
5.46
growth rate -68.6% 129.3% -20.2% -5.1% 25.6% 5.7% -41.1% 45.1% 1.7% -25.2%
Cur. Ratio 2.06
1.95
1.65
1.66
1.69
1.67
1.89
1.91
2.12
1.35
2.39
growth rate -5.3% -15.4% 0.6% 1.8% -1.2% 13.2% 1.1% 11.0% -36.3% 77.0%
Quick Ratio 0.90
0.89
0.73
0.74
0.75
0.75
0.83
0.88
1.04
0.67
1.19
growth rate -1.1% -18.0% 1.4% 1.4% 0.0% 10.7% 6.0% 18.2% -35.6% 77.6%
Leverage 1.92
2.00
2.09
2.04
1.93
1.84
3.17
3.27
2.79
2.95
2.59
growth rate 4.2% 4.5% -2.4% -5.4% -4.7% 72.3% 3.2% -14.7% 5.7% -12.2%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 0.00
86.00
85.00
89.00
76.72
79.12
163.29
189.67
150.43
145.93
140.34
growth rate -1.2% 4.7% -13.8% 3.1% 106.4% 16.2% -20.7% -3.0% -3.8%
Acct.Payable 39.00
48.00
39.00
35.99
38.20
107.52
122.78
78.70
81.80
67.76
growth rate 23.1% -18.8% -7.7% 6.1% 181.5% 14.2% -35.9% 3.9% -17.2%
Cur.Assets 205.00
208.00
212.00
223.00
214.87
223.74
510.21
621.51
558.14
606.55
515.23
growth rate 1.5% 1.9% 5.2% -3.7% 4.1% 128.0% 21.8% -10.2% 8.7% -15.1%
Total Assets 394.30
422.00
450.00
461.00
459.55
475.63
902.50
1,028.15
953.59
1,080.81
1,008.87
growth rate 7.0% 6.6% 2.4% -0.3% 3.5% 89.8% 13.9% -7.3% 13.3% -6.7%
Cash 8.80
9.00
8.00
10.00
18.43
20.40
54.39
96.55
75.39
106.76
81.42
growth rate 2.3% -11.1% 25.0% 84.3% 10.7% 166.6% 77.5% -21.9% 41.6% -23.7%
Inventory 89.00
91.00
104.00
105.00
97.31
99.96
216.66
261.89
270.48
280.84
236.59
growth rate 2.3% 14.3% 1.0% -7.3% 2.7% 116.8% 20.9% 3.3% 3.8% -15.8%
Cur.Liabilities 99.70
106.00
128.00
134.00
126.89
133.34
266.91
325.36
263.08
449.54
215.93
growth rate 6.3% 20.8% 4.7% -5.3% 5.1% 100.2% 21.9% -19.1% 70.9% -52.0%
Liabilities 189.00
211.00
235.00
235.00
221.29
216.53
620.06
713.35
611.45
714.05
619.68
growth rate 11.6% 11.4% 0.0% -5.8% -2.2% 186.4% 15.1% -14.3% 16.8% -13.2%
LT Debt 0.00
86.00
78.00
65.00
59.71
42.24
300.00
329.60
284.69
189.51
332.18
growth rate -9.3% -16.7% -8.2% -29.3% 610.3% 9.9% -13.6% -33.4% 75.3%
Equity 205.30
210.50
214.80
226.20
238.26
259.10
282.44
314.80
342.14
366.76
389.19
growth rate 2.5% 2.0% 5.3% 5.3% 8.8% 9.0% 11.5% 8.7% 7.2% 6.1%
Common Shares 13.00
12.00
13.00
13.00
13.00
13.00
13.00
13.00
13.00
13.00
13.00
growth rate -7.7% 8.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 30.10
39.00
40.00
30.00
37.22
21.48
20.86
33.63
26.38
32.72
38.92
growth rate 29.6% 2.6% -25.0% 24.1% -42.3% -2.9% 61.2% -21.6% 24.0% 19.0%
Cash Dividends 6.80
6.80
5.50
5.50
6.09
6.10
6.09
8.01
10.75
10.70
10.66
growth rate 0.0% -19.1% 0.0% 10.7% 0.2% -0.1% 31.4% 34.1% -0.4% -0.4%
Cash From OA 37.20
37.00
41.00
45.00
59.28
59.98
65.65
38.69
56.05
76.92
131.27
growth rate -0.5% 10.8% 9.8% 31.7% 1.2% 9.5% -41.1% 44.9% 37.2% 70.7%
FCF per Share 0.45
-0.27
-0.19
0.80
1.26
1.68
2.87
1.61
-1.58
1.78
2.48
growth rate -100.0% 0.0% 100.0% 57.5% 33.3% 70.8% -43.9% -100.0% 100.0% 39.3%
Sale Purchase of Stock 0.23
0.23
2.09
2.45
0.97
growth rate 0.0% 826.7% 17.4% -60.4%
FCF 6.00
-3.00
2.00
10.00
23.00
29.00
38.00
-11.00
10.00
33.00
72.00
growth rate -100.0% 100.0% 400.0% 130.0% 26.1% 31.0% -100.0% 100.0% 230.0% 118.2%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 335.50
354.00
379.00
404.00
390.60
409.51
489.91
776.47
808.63
794.61
819.00
growth rate 5.5% 7.1% 6.6% -3.3% 4.8% 19.6% 58.5% 4.1% -1.7% 3.1%
Op.Income 29.72
6.00
14.00
20.00
27.53
39.19
60.01
56.01
81.01
66.09
52.86
growth rate -79.8% 133.3% 42.9% 37.6% 42.4% 53.1% -6.7% 44.7% -18.4% -20.0%
IBT 26.00
5.10
18.00
27.70
27.71
36.25
60.92
47.06
66.81
66.44
51.21
growth rate -80.4% 252.9% 53.9% 0.0% 30.8% 68.1% -22.8% 42.0% -0.6% -22.9%
Net Income 20.50
6.00
14.00
20.00
20.49
26.13
39.23
28.93
46.22
46.82
37.33
growth rate -70.7% 133.3% 42.9% 2.5% 27.5% 50.2% -26.3% 59.8% 1.3% -20.3%
EPS 1.64
0.47
1.12
1.61
1.62
2.07
3.13
2.29
3.65
3.70
2.95
growth rate -71.3% 138.3% 43.8% 0.6% 27.8% 51.2% -26.8% 59.4% 1.4% -20.3%
Gross Profit 253.40
248.00
274.00
282.00
284.71
310.64
376.64
566.95
595.97
580.83
597.51
growth rate -2.1% 10.5% 2.9% 1.0% 9.1% 21.3% 50.5% 5.1% -2.5% 2.9%

Quarterly Statements

Item Name Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Earnings BIT 14.74
11.13
11.13
15.30
15.30
growth rate -24.4% 0.0% 37.4% 0.0%
Balance Sheet Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Acct.Receivable 145.93
144.67
144.67
140.34
140.34
growth rate -0.9% 0.0% -3.0% 0.0%
Acct.Payable 81.80
69.11
69.11
67.76
67.76
growth rate -15.5% 0.0% -2.0% 0.0%
Cur.Assets 606.55
573.63
573.63
515.23
515.23
growth rate -5.4% 0.0% -10.2% 0.0%
Total Assets 1,080.81
1,068.43
1,068.43
1,008.87
1,008.87
growth rate -1.2% 0.0% -5.6% 0.0%
Cash 106.76
75.85
75.85
81.42
81.42
growth rate -29.0% 0.0% 7.3% 0.0%
Inventory 280.84
287.12
287.12
236.59
236.59
growth rate 2.2% 0.0% -17.6% 0.0%
Cur.Liabilities 449.54
288.52
288.52
215.93
215.93
growth rate -35.8% 0.0% -25.2% 0.0%
Liabilities 714.05
700.54
700.54
619.68
619.68
growth rate -1.9% 0.0% -11.5% 0.0%
LT Debt 189.51
331.39
331.39
332.18
332.18
growth rate 74.9% 0.0% 0.2% 0.0%
Equity 366.76
367.88
367.88
389.19
389.19
growth rate 0.3% 0.0% 5.8% 0.0%
Common Shares 12.58
12.58
12.58
12.60
12.60
growth rate 0.0% 0.0% 0.1% 0.0%
Cash Flow Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Capital Expenditures 11.38
8.15
8.15
11.31
11.31
growth rate -28.4% 0.0% 38.6% 0.0%
Cash Dividends 0.00
5.34
5.34
growth rate 356,100.0% 0.0%
Cash From OA 29.69
14.53
14.53
51.11
51.11
growth rate -51.1% 0.0% 251.7% 0.0%
Sale Purchase of Stock
growth rate
FCF 18.31
6.38
6.38
39.80
39.80
growth rate -65.2% 0.0% 524.3% 0.0%
Income Statement Dec '18 Mar '19 Jun '19 Sep '19 Dec '19
Sales 201.95
201.36
201.36
208.14
208.14
growth rate -0.3% 0.0% 3.4% 0.0%
Op.Income 14.74
11.13
11.13
15.30
15.30
growth rate -24.4% 0.0% 37.4% 0.0%
IBT 17.04
12.36
12.36
13.24
13.24
growth rate -27.5% 0.0% 7.1% 0.0%
Net Income 12.20
9.52
9.52
9.15
9.15
growth rate -22.0% 0.0% -3.9% 0.0%
Gross Profit 133.33
161.68
161.68
137.08
137.08
growth rate 21.3% 0.0% -15.2% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (65.51)

YOY Growth Grade:

D (49.72)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 10.27 11.36 9.21
EPS / Growth 21.6% 2.95 36.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.5% 21.9% 21.9%
Future PE 9.21 9.92 21.11
Future EPS 6.07 21.41 21.41
Value Price
MOS %
13.83
-58.7%
52.48
56.6%
111.69
233.4%
MOS Price 6.91 26.24 55.84
IRT 8.07 5.59 5.59

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.